Brian M Posner
CIK 1287711 · Chief Financial Officer · last filed 2026-09-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
ALQA price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
PENNINGTON, NJ 08534
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| AIFF | Director | — | $0.94 | — | $0 | 3 | 2026-09-29 |
| SWAG | Director | 14,564 | $1.34 | $19.5K | $0 | 1 | 2026-08-14 |
| ECOR | Chief Financial Officer | 22,437 | $7.44 | $166.9K | $28.4K | 10 | 2024-01-17 |
| Cellectar Biosciences, Inc. (CLRBZ) Delisted | Chief Financial Officer | — | $0.12 | — | $0 | 3 | 2019-01-18 |
| Alliqua BioMedical, Inc. (ALQA) Delisted | Chief Financial Officer | 79,404 | — | — | $48.5K | 12 | 2017-09-25 |
| OPTT | Chief Financial Officer | 2 | $0.60 | $1 | $18.2K | 8 | 2013-07-17 |
| PHARMACOPEIA INC (PCOP) Delisted | EVP, CFO | 0 | — | — | $8.9K | 21 | 2008-12-24 |
Recent Filings · Page 2 of 6
60 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-01-20 | ECOR | Grant (A) | — | $0 | EDGAR |
| 2020-06-16 | ECOR | Grant (A) | — | $0 | EDGAR |
| 2019-07-01 | ECOR | Grant (A) | — | $0 | EDGAR |
| 2019-06-06 | ECOR | Buy (P) | +10,000 | $17.2K | EDGAR |
| 2019-01-18 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-10-15 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-04-06 | Cellectar Biosciences, Inc. (CLRBZ) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-09-25 | Alliqua BioMedical, Inc. (ALQA) Delisted | Tax (F) | −70,833 | -$29.7K | EDGAR |
| 2017-06-28 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +100,000 | $0 | EDGAR |
| 2017-06-26 | Alliqua BioMedical, Inc. (ALQA) Delisted | Grant (A) | +205,715 | $0 | EDGAR |
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.